A股異動丨德威新材漲停 新能源汽車發展規劃含燃料電池內容
格隆匯11月29日丨德威新材(300325.SZ)漲停,報3.5元,總市值35億元。工信部聯合多家單位組成編寫組,形成了《2021年-2035年新能源汽車發展規劃》初稿,並徵求了地方行業主管部門和《規劃》諮詢委意見。其中,提到了燃料電池汽車產業發展的有關內容。根據計劃,上述發展規劃在年底左右形成上報稿。德威新材此前擬以自有資金1億元在上海設立一家全資子公司“上海德威互興氫能科技有限公司”,德威互興氫能主營業務為氫燃料電池的研發、生產、銷售等。德威互興氫能將進入的氫燃料電池領域,是公司未來發展戰略主要方向之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.